*Dermatology is further sub segmented into plastic surgery and androgenic alopecia
. *Based on end user, global plasma therapy market is segmented into hospitals, clinics and research institutes.
Among the patients with alopecia (7 cases, 14%), androgenic alopecia
was found in 3 (6%) patients and remaining 4 (8%) had telogen effluvium.
Its pipeline consists of potential novel therapeutics for hyperhidrosis, cutaneous T-cell lymphoma, psoriasis, androgenic alopecia
and allergic contact dermatitis.
The researchers identified seven studies that used platelet-rich plasma alone for facial rejuvenation, seven in combination with fat grafting, two for treatment of acne scarring, and six for treatment of androgenic alopecia
. Even though the majority of studies in this review report positive results, significant variation exists in preparation protocols and in the number and frequency of clinical treatments.
The aim of our study was to evaluate the safety, efficacy and feasibility of PRP for treatment of androgenic alopecia
in both male and females by staging the patient based on Norwood-Hamilton scale and Ludwig classification respectively.
An early onset of androgenic alopecia
is associated with an increased incidence of the metabolic syndrome and an increased risk of the cardiac ischaemic disease .
"Premature greying and androgenic alopecia
(malepattern baldness) correlate well with vascular age irrespective of chronological age and are plausible risk factors for coronary artery disease."
Male pattern baldness, also called androgenic alopecia
, is the most common type of hair loss in men.
(1) Finasteride is used as an oral drug for the treatment of benign prostatic hyperplasia at the 5 mg/day dose and is also used for the treatment of androgenic alopecia
, or male pattern hair loss, at a dosage of 1 mg orally.
Male pattern hair loss (MPHL), or androgenic alopecia
, is the most prevalent type of hair loss in men.
Cell therapy company Cytori Therapeutics (NasdaqGM:CYTX) announced on Tuesday that Kerastem Technologies has received conditional approval from the US Food and Drug Administration's (FDA) Investigational Device Exemption (IDE) to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia